IL4R and atopic eczema: Although our conclusion regarding the mechanism is theoretical and other mechanisms of developing LP were explored, our theory is plausible based on the similar phenomenon of psoriasis patients developing atopic dermatitis during IL-17/23 blockade and atopic dermatitis patients developing psoriasis during treatment with dupilumab which blocks IL-4R/13.5